-
Cyanine 3 Tyramide for Claustrum Gene Mapping
2026-09-04
Cyanine 3 Tyramide combines orange fluorescence with Tyramide Signal Amplification for sensitive gene and protein detection in anatomically challenging brain sections. This guide translates comparative claustrum research into practical in situ hybridization, immunohistochemistry, multiplex imaging, and troubleshooting workflows.
-
Palomid 529 in ESCC: A Pathway-Testing Strategy
2026-09-04
Palomid 529 (P529) offers a dual-mTOR approach for investigating the PI3K/Akt/mTOR signaling pathway in esophageal squamous cell carcinoma. This article translates the RCN2–PPP2CA mechanism into a practical framework for studying metastasis, cisplatin resistance, angiogenesis, and radiotherapy enhancement.
-
Cabazitaxel (XRP6258): Resistant-Model Workflow
2026-09-03
Cabazitaxel (XRP6258) is a semi-synthetic taxane derivative for investigating microtubule-dependent proliferation, particularly in taxane-resistant and P-glycoprotein-expressing cancer models. It is suitable for carefully controlled DMSO- or ethanol-based workflows, but not for aqueous formulation or long-term storage of prepared solutions.
-
TCN1 Links DNA Hypomethylation to Psoriasis
2026-09-03
Wang et al. identify transcobalamin 1 (TCN1) as a DNA hypomethylation-reactivated autoantigen that connects keratinocyte biology with HLA class II antigen presentation and T helper 17 immunity in psoriasis. The study’s integrated transcriptomic, methylomic, immunopeptidomic, and coculture strategy provides a useful framework for discovering disease-associated autoantigens while clarifying the limits of translation from human tissue to experimental models.
-
Isoprinosine: Antiviral Workflows and HSV-1 Insights
2026-09-02
Isoprinosine, or inosine pranobex, supports antiviral research by combining immune-response modulation with measurable viral replication endpoints. This guide pairs practical compound-handling and infection workflows with the CLCC1 nuclear-egress discovery, while clearly separating established evidence from exploratory assay design.
-
2'3'-cGAMP: From Senescence Signal to Strategy
2026-09-02
2'3'-cGAMP (sodium salt) provides a direct, high-affinity way to interrogate STING signaling in cancer models. This article connects cGAS-STING biology with the senescence-associated secretory phenotype described in small cell lung cancer, translating mechanistic findings into practical assay design, controls, and translational decision-making.
-
HNRNPU K181 Lactylation Rewires Cervical Cancer
2026-09-01
This Advanced Science study identifies HNRNPU lysine 181 lactylation as a lactate-responsive switch that stabilizes HNRNPU, preserves PHGDH mRNA, and activates serine biosynthesis in cervical cancer. Its integrated molecular, metabolic, cellular, and in vivo evidence connects a non-histone post-translational modification to tumor growth and suggests a testable framework for studying metabolic vulnerabilities.
-
STING Agonist-1: From TLS Biology to Translation
2026-09-01
A mechanistic and strategic guide to using STING agonist-1 to investigate type I interferon signaling, CD40–TRAF2–IRF4 biology, tertiary lymphoid structures, and translational opportunities in immunology and cancer research.
-
MLN4924: Designing Neddylation Mechanism Assays
2026-08-31
MLN4924 is a selective NEDD8-activating enzyme inhibitor for dissecting protein degradation, cell-cycle control, and treatment resistance. This article develops an assay-centered framework linking neddylation pathway inhibition with cyclin D3 turnover and trastuzumab resistance without assuming that every degradation phenotype is CRL-dependent.
-
Neomycin sulfate: Workflows for RNA/DNA Studies
2026-08-31
Neomycin sulfate is a water-soluble aminoglycoside antibiotic that converts nucleic-acid structure and ion-channel biology into experimentally tractable perturbations. This guide pairs practical assay workflows with controls for hammerhead ribozymes, Tat/TAR RNA, DNA triplexes, and ryanodine receptors while clearly separating established mechanisms from exploratory applications.
-
EdU Imaging Kits (488): Reliable S-Phase Data
2026-08-30
Learn how EdU Imaging Kits (488), SKU K1175, support reproducible S-phase DNA synthesis measurement in microscopy and flow cytometry workflows. This scenario-based guide addresses assay interpretation, immunofluorescence compatibility, protocol optimization, and practical product selection.
-
MRSA Extracellular Vesicles Drive OSCC via IL-8
2026-08-29
A 2026 study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus can promote oral squamous cell carcinoma through an ERK/c-Jun–IL-8–CXCR1 signaling circuit. The work links antibiotic resistance to tumor biology and identifies bacterial vesicle cargo, IL-8 loss, and CXCR1 blockade as experimentally useful points for mechanistic validation.
-
CD40–STING–TRAF2 Signaling in ESCC TLS
2026-08-28
A 2025 study in Cancer Gene Therapy links tertiary lymphoid structures with favorable survival in treatment-naïve esophageal squamous cell carcinoma and identifies IRF4-positive, tumor-infiltrating B cells as a central immune population. Its mechanistic data indicate that CD40 and STING compete for TRAF2, influencing non-canonical NF-κB signaling, STING post-translational regulation, and IRF4-mediated B cell activation.
-
Deferasirox for HCC Ferroptosis Research
2026-08-28
Deferasirox provides a practical way to perturb chelatable iron while connecting iron-overload biology with ferroptosis research in hepatocellular carcinoma. This guide translates the METTL16–SENP3–LTF findings into controlled cell, organoid, and translational assay workflows, with troubleshooting for solubility, oxygen, and endpoint interpretation.
-
CRISPR Live-Cell Imaging of Non-Repetitive Loci
2026-08-27
The reference study introduces CRISPR PRO-LiveFISH, a live-cell imaging strategy that combines orthogonal bases with rational sgRNA design to visualize multiple endogenous, non-repetitive genomic loci. By reducing guide requirements and avoiding signal amplification, the method enables analysis of enhancer–promoter dynamics, chromatin mobility, and epigenetic-state relationships in diverse cells, including primary cells.